These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 15535255)

  • 1. [Tumor markers for carcinoma of the endometrium].
    Yokoyama M; Uchiyama M; Iwasaka T; Fukuda K
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():299-302. PubMed ID: 15535255
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical evaluation of several tumor markers in the chest surgery].
    Miyazato I; Tojo N
    Rinsho Kyobu Geka; 1988 Jun; 8(3):231-6. PubMed ID: 9301836
    [No Abstract]   [Full Text] [Related]  

  • 3. [Tumor markers for ovarian cancers].
    Aoki D; Kataoka F; Susumu N; Nozawa S
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():496-502. PubMed ID: 15535295
    [No Abstract]   [Full Text] [Related]  

  • 4. Tumor markers in patients with pancreatic carcinoma.
    Gattani AM; Mandeli J; Bruckner HW
    Cancer; 1996 Jul; 78(1):57-62. PubMed ID: 8646727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [CA-125 antigen].
    Zakrzewska I
    Postepy Hig Med Dosw; 2002; 56(1):29-38. PubMed ID: 11987487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [An autopsy case of thymic carcinoma producing various tumor markers and the examination of 222 autopsy cases of thymic malignant tumor in Japan].
    Takase K; Adachi Y; Yasumizu R; Toki J; Jin T; Oyaizu H; Ikehara S; Takase K; Kinoshita T; Okamura A; Wakamatsu M; Inoue K; Kato Y
    Kyobu Geka; 2000 Jun; 53(6):450-6. PubMed ID: 10846355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neoplasm markers useful for diagnosis and monitoring of colonic neoplasms].
    Ławicki S; Mroczko B; Szmitkowski M
    Postepy Hig Med Dosw; 2002; 56(5):617-34. PubMed ID: 12596691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serous papillary adenocarcinoma of the female genital organs and invasive micropapillary carcinoma of the breast. Are WT1, CA125, and GCDFP-15 useful in differential diagnosis?
    Moritani S; Ichihara S; Hasegawa M; Endo T; Oiwa M; Yoshikawa K; Sato Y; Aoyama H; Hayashi T; Kushima R
    Hum Pathol; 2008 May; 39(5):666-71. PubMed ID: 18339419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Retroperitoneal cystadenoma containing elevated concentrations of CA125 and CA19-9 in the cyst fluid: a case report].
    Sanefuji T
    Hinyokika Kiyo; 2000 Jul; 46(7):457-61. PubMed ID: 10965450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of tumour markers in nasopharyngeal carcinoma.
    Kuo WR; Tsai SM; Jong SB; Juan KH
    J Otolaryngol; 1996 Feb; 25(1):32-6. PubMed ID: 8816107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TATI (tumor associated trypsin inhibitor) and cancer antigen 125 (CA 125) in patients with early-stage endometrial cancer.
    Peters-Engl C; Buxbaum P; Ogris E; Sevelda P; Medl M
    Anticancer Res; 1998; 18(6B):4635-9. PubMed ID: 9891532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring endometrial adenocarcinoma with a four tumor marker combination. CA 125, squamous cell carcinoma antigen, CA 19.9 and CA 15.3.
    Matorras R; Rodríguez-Escuderoi FJ; Diez J; Genollá J; Cruz Fombellida J; Ruibal A
    Acta Obstet Gynecol Scand; 1992 Aug; 71(6):458-64. PubMed ID: 1326844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Misleading CA-125 levels and computed tomography images in an endometrial cancer patient.
    Tjalma WA
    J Obstet Gynaecol; 2004 Jun; 24(4):470-1. PubMed ID: 15203605
    [No Abstract]   [Full Text] [Related]  

  • 14. The significance of CEA, CA19-9 and CA72-4 in the detection of colorectal carcinoma recurrence.
    Holubec L; Topolcan O; Pikner R; Pecen L; Vaclavickova J; Wirthova M; Molacek J; Stieber P; Holdenrieder S; Sen LH; Finek J
    Anticancer Res; 2000; 20(6D):5237-44. PubMed ID: 11326702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The proapoptotic factor HLDF in the normal, hyperplastic and neoplastic endometrium].
    Koviazin VA; Shchelokova EE; Kostanian IA; Dranitsyna SM; Frolova II; Babichenko II
    Arkh Patol; 2007; 69(3):23-6. PubMed ID: 17722590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of serum biomarkers for detection of early- and late-stage endometrial cancer.
    Farias-Eisner G; Su F; Robbins T; Kotlerman J; Reddy S; Farias-Eisner R
    Am J Obstet Gynecol; 2010 Jan; 202(1):73.e1-5. PubMed ID: 19766980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tumor markers in biliary tract cancer].
    Najima M; Okusaka T
    Nihon Rinsho; 2006 Jan; 64 Suppl 1():419-21. PubMed ID: 16457296
    [No Abstract]   [Full Text] [Related]  

  • 18. Primary endodermal sinus tumor of the endometrium presenting as "recurrent" endometrial adenocarcinoma.
    Talerman A
    Gynecol Oncol; 2002 Jan; 84(1):184. PubMed ID: 11749000
    [No Abstract]   [Full Text] [Related]  

  • 19. [Possibility of the combined use of tumor markers in endometrial carcinoma].
    Indraccolo SR; Cecchi A; Thodos A; Brandi S; Carta G
    Minerva Ginecol; 1991 Oct; 43(10):461-3. PubMed ID: 1722568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of tumor marker CA 125 in the treatment of ovarian cancer].
    Porsbjerg CM; Sørensen JB; Lund BA
    Ugeskr Laeger; 1998 Feb; 160(7):995-1000. PubMed ID: 9477746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.